Multisensory Patch to Measure Healthy and Abnormal Surgical Incision Healing

NCT ID: NCT07055308

Last Updated: 2025-07-08

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

18 participants

Study Classification

INTERVENTIONAL

Study Start Date

2023-10-16

Study Completion Date

2024-10-22

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Abdominal surgical incisions often lead to superficial surgical site infection (SSI). SSI is characterized by heat (calor), pain (dolor), redness (rubor), and swelling (tumor). The aim of this study is to measure calor, rubor and tumor with electronic sensors. Therefore, a multisensory patch is proposed which measures the tissue surrounding the incision once per day.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Abdominal Surgery Patients

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

BASIC_SCIENCE

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SeaPatch

Daily measurement with multisensory patch from day 1 post-surgery maximally up to the day of discharge from hospital.

Group Type EXPERIMENTAL

SEAPatch

Intervention Type DEVICE

Daily measurement with multisensory patch from day 1 post-surgery maximally up to the day of discharge from hospital.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SEAPatch

Daily measurement with multisensory patch from day 1 post-surgery maximally up to the day of discharge from hospital.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* The subject requires acute abdominal surgery due to perforation of the intestinal tractus (i.e., contamination upfront).
* The subject's incision is closed with either sutures or staples (by primary intention).
* The subject is 18 years or older.
* The subject can understand the patient information/ consent form and is capable of making his/her own decision.
* The subject is accompanied by an acquaintance who can give the second consent.

Exclusion Criteria

* The subject has a known allergy to (silicon) adhesives.
* The subject states to be pregnant or planning to become pregnant.
* The subject receives medication that is contraindicated to excessive light exposure (e.g. Tetracylines, Doxycycline, Phenothiazines, Dacarbazine, Ketoprofen, Lomefloxacin). This criterion will be implemented in order to exclude the possibility of local skin irritation from prolonged irradiation by LED-light.
* The subject has an implantable device with a battery (i.e. pacemaker or other active implant).
* The subject has tattoos on the abdomen.
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Stichting IMEC-NL

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Responsibility Role SPONSOR

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Ziekenhuis Oost Limburg

Genk, , Belgium

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Belgium

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

CIV-23-06-043226

Identifier Type: OTHER

Identifier Source: secondary_id

IM-NL-STUDY-2022-0028

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Management of Burst Abdomen
NCT07229703 COMPLETED